🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

MISTER Study: Minimally Invasive Steam Therapy - Russian Effectiveness Registry

RecruitingNAAges 18 Years - 85 YearsMaleSechenov University
NCT07723378 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Rezūm is a minimally invasive procedure that uses water vapor (steam) to treat urinary symptoms caused by an enlarged prostate (benign prostatic hyperplasia, BPH). It has been used in clinical practice since receiving FDA approval in 2015 and is recommended as a treatment option for men with moderate-to-severe urinary symptoms, including those who wish to preserve ejaculatory function. Clinical trials have shown that Rezūm improves urinary symptoms and flow rates, with benefits that last for at least five years, a low reoperation rate, and a low risk of sexual side effects. Despite this evidence, several important questions remain. It is not well understood which patients are more likely to experience temporary urinary retention after the procedure, need repeat treatment, or develop ejaculatory changes. Standardized criteria for defining overall treatment success are also lacking. The

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria * Lower urinary tract symptoms (IPSS ≥8 points; QoL ≥3 points) due to BPH * Prostate volume of 30-150 cm³ * Qmax ≤15 mL/s; post-void residual urine volume \<300 mL Non-Inclusion Criteria * Prostate cancer * Acute infections of the urinary tract, prostate, or scrotal organs * Neurogenic lower urinary tract dysfunction * Bladder stone(s) * Urethral stricture * Prior prostate surgery Exclusion Criteria * Patient refusal to allow use of medical data for scientific analysis * Missing or lost data required for analysis
💊

What it tests

  • Rezūm
📍

Where

1 site
Institute for Urology and Reproductive Health, Sechenov University
Moscow, Russia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy